Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,443.00p

Buy

1,445.00p

arrow-up32.50p (+2.30%)

Prices updated at 06 May 2026, 15:45 BST

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

FTSE All-Share

2.11%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	1,448.00p - 1,420.00p
	2,164.00p - 1,187.00p
	4.41
	3,030.26m
	10.55
	500
	149,067
	1.58
	816,552.24
	0.43
	234.72m
	GB00B0LCW083
	1.81
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.